Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Phase 1b Study of Secukinumab in Patients With Moderate to Severe Papulopustular Rosacea

NCT03079531 is registered in ClinicalTrials.gov with Anne Chang as lead sponsor.

NCT NCT03079531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Phase 1b Study of Secukinumab in Patients With Moderate to Severe Papulopustular Rosacea
Lead sponsor
Anne Chang
Phase
Phase 1/2
Overall status
Completed
Start date
June 21, 2017
Completion date
January 25, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea